| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $891.3M | +27.1% |
| Cost of Revenue | $1.40B | +56.2% |
| Gross Profit | -$507.8M | -161.3% |
| R&D Expense | $113.7M | +14.2% |
| SG&A Expense | $422.5M | +16.1% |
| Operating Income | -$1.34B | -97.7% |
| Interest Expense | $45.2M | +15.8% |
| Pre-tax Income | -$1.38B | -90.3% |
| Income Tax | -$7.4M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $135.0M | -80.4% |
| Accounts Receivable | $243.8M | +88.3% |
| Inventory | $961.3M | +48.9% |
| Current Assets | $1.79B | -45.9% |
| Total Assets | $4.90B | -14.9% |
| Current Liabilities | $964.8M | +51.9% |
| Long-term Debt | $3.9M | -56.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.11B | -33.5% |
| Capital Expenditures | $665.2M | +52.4% |
| Investing Cash Flow | $728.1M | +207.2% |
| Financing Cash Flow | $6.1M | +107.9% |
| Free Cash Flow | -$1.77B | -40.0% |
| -977.7% |
| Net Income | -$1.37B | -89.1% |
| EPS (Basic) | -$2.30 | -84.0% |
| EPS (Diluted) | -$2.30 | -84.0% |
| Total Liabilities |
| $2.00B |
| +17.6% |
| Stockholders' Equity | $2.90B | -28.6% |